Xperi Inc.
NYSE:XPERSemiconductors
+$0.18 today
- Market cap
- $281.20M
- Beta
- 0.95
- P/E (TTM)
- -18.8
- EPS (TTM)
- -$0.42
Volume 0.29M
Average 0.41M
XPER Purchases of Investments
Cash used to buy marketable securities and other investments.
Xperi Inc.NYSE: XPER
Purchases of Investments · Q1 FY2026 · quarter ended Mar 2026
Purchases of investments turns negative
Q1 FY2026 purchases of investments was -$9.03M, compared with $0 a year earlier. Trailing-twelve-month purchases of investments was -$9.03M.
Context
- Purchases of investments amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Purchases of investments increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly purchases of investments holds near -$9.03M or moves back toward the trailing-twelve-month quarterly average of -$2.26M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Purchases of Investments history
USD · from the cash flow
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Purchases of Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | +100.0% |
| FY2022 | 2022-12-31 | (4.49M) | — |
| FY2021 | 2021-12-31 | 0 | — |
Purchases of Investments vs competitors
How XPER compares with its peers on the latest reported figures
- XPER's LTM Mar 2026 purchases of investments of $9.03M is the 4th largest of the 10 companies compared; the peer median is $0.
- Purchases of investments amounts to 2.0% of revenue for XPER, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $305.57M | +36450.8% | -27.1% | 243.5% | |
| LTM Mar 2026 | $81.62M | -39.1% | -21.1% | 115.5% | |
| LTM Mar 2026 | $15.24M | +35.1% | -18.8% | 57.9% | |
| LTM Mar 2026 | $9.03M | — | — | 2.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | +100.0% | — | 0.0% | |
| Peer median (excluding XPER) | $0 | +67.6% | -21.1% | 0.0% | |
Competitors are the stored peer set for XPER. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (179.08M) | (761.21M) | (139.69M) | (869K) | (56.34M) |
| Depreciation & Amortization | 127.9M | 82.71M | 74.4M | 56.01M | 48.27M |
| Deferred Income Tax | 6.91M | (1.6M) | (8.6M) | (2.93M) | 2.26M |
| Stock-Based Compensation | 33.51M | 45.3M | 69.53M | 60.54M | 40.68M |
| Change in Working Capital | (10.94M) | (5.95M) | 1.96M | (71.77M) | (36.41M) |
| Accounts Receivables | 13.06M | 17.51M | (13.67M) | (51.81M) | (18.6M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | (4.02M) | 6.63M | 5.07M | (3.04M) | (4.7M) |
| Other Working Capital | (19.98M) | (30.09M) | 10.55M | (16.92M) | (13.12M) |
| Other Non-Cash Items | (1.75M) | 612.3M | 2.46M | (96.32M) | 1.03M |
| Operating Cash Flow | (23.45M) | (28.45M) | 62K | (55.34M) | (515K) |
| Capital Expenditures | (9.08M) | (14.37M) | (12.93M) | (16.95M) | (20.98M) |
| Acquisitions (Net) | (12.4M) | (50.47M) | 0 | 67.77M | 0 |
| Purchases of Investments | 0 | (4.49M) | 0 | 0 | 0 |
| Sales of Investments | 0 | 64.83M | 0 | 0 | 0 |
| Other Investing Activities | (186K) | (60.34M) | (12.93M) | (11.91M) | (15.6M) |
| Investing Cash Flow | (21.48M) | (64.85M) | (12.93M) | 50.82M | (20.98M) |
| Debt Repayment | 0 | 0 | 0 | 0 | (8.9M) |
| Common Stock Issued | 0 | 83.24M | 0 | 0 | 5.97M |
| Common Stock Repurchased | 0 | 0 | 0 | (19.99M) | (1.1M) |
| Dividends Paid | 0 | (20.89M) | 0 | 0 | 0 |
| Other Financing Activities | 83.33M | 73.4M | 7.05M | 640K | (8.22M) |
| Financing Cash Flow | 83.33M | 135.75M | 7.05M | (19.35M) | (12.24M) |
| Effect of Forex Changes | (3.33M) | (3.03M) | 126K | 0 | 0 |
| Net Change in Cash | 35.07M | 39.43M | (5.69M) | (23.87M) | (33.74M) |
| Free Cash Flow | (32.53M) | (42.82M) | (12.87M) | (72.29M) | (21.5M) |
Xperi Inc.
NYSE:XPER
Intrinsic Alpha fair value
Locked
Current Price
$5.76
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.